97 related articles for article (PubMed ID: 22387973)
21. Analytical and clinical performance of different platforms simultaneously detecting 15 antinuclear antibodies.
Qin Y; Fan C; Wang Y; Feng M; Liang Z; Zhao X; Gao C; Luo J
J Clin Lab Anal; 2022 Jul; 36(7):e24554. PubMed ID: 35708068
[TBL] [Abstract][Full Text] [Related]
22. The Past, Present, and Future in Antinuclear Antibodies (ANA).
Irure-Ventura J; López-Hoyos M
Diagnostics (Basel); 2022 Mar; 12(3):. PubMed ID: 35328200
[TBL] [Abstract][Full Text] [Related]
23. Comparison study of bead-based and line-blot multiplex ANA immunoassays in the diagnosis of systemic autoimmune rheumatic diseases.
Yuan W; Cao H; Li W; Wu X; Zheng J
Clin Rheumatol; 2022 Mar; 41(3):899-909. PubMed ID: 34626262
[TBL] [Abstract][Full Text] [Related]
24. Properties of Uncommon Indirect Immunofluorescence Staining Patterns Determined during Antinuclear Antibody Detection on HEp-2 Cells.
Tomić Sremec N; Kozmar A; Sremec J; Anić B; Batinić D
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501315
[TBL] [Abstract][Full Text] [Related]
25. Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.
Muñoz-Grajales C; Prokopec SD; Johnson SR; Touma Z; Ahmad Z; Bonilla D; Hiraki L; Bookman A; Boutros PC; Chruscinski A; Wither J
Rheumatology (Oxford); 2022 Mar; 61(3):1092-1105. PubMed ID: 34175923
[TBL] [Abstract][Full Text] [Related]
26. Likelihood Ratio Approach and Clinical Interpretation of Laboratory Tests.
Fierz W; Bossuyt X
Front Immunol; 2021; 12():655262. PubMed ID: 33936083
[No Abstract] [Full Text] [Related]
27. Clinical utility of ANA-ELISA vs ANA-immunofluorescence in connective tissue diseases.
Alsaed OS; Alamlih LI; Al-Radideh O; Chandra P; Alemadi S; Al-Allaf AW
Sci Rep; 2021 Apr; 11(1):8229. PubMed ID: 33859213
[TBL] [Abstract][Full Text] [Related]
28. Understanding and interpreting antinuclear antibody tests in systemic rheumatic diseases.
Bossuyt X; De Langhe E; Borghi MO; Meroni PL
Nat Rev Rheumatol; 2020 Dec; 16(12):715-726. PubMed ID: 33154583
[TBL] [Abstract][Full Text] [Related]
29. Opto-Microfluidic Immunosensors: From Colorimetric to Plasmonic.
He JL; Wang DS; Fan SK
Micromachines (Basel); 2016 Feb; 7(2):. PubMed ID: 30407402
[TBL] [Abstract][Full Text] [Related]
30. Automated Processing and Evaluation of Anti-Nuclear Antibody Indirect Immunofluorescence Testing.
Ricchiuti V; Adams J; Hardy DJ; Katayev A; Fleming JK
Front Immunol; 2018; 9():927. PubMed ID: 29780386
[TBL] [Abstract][Full Text] [Related]
31. Autoantibodies Associated With Connective Tissue Diseases: What Meaning for Clinicians?
Didier K; Bolko L; Giusti D; Toquet S; Robbins A; Antonicelli F; Servettaz A
Front Immunol; 2018; 9():541. PubMed ID: 29632529
[TBL] [Abstract][Full Text] [Related]
32. Personalized medicine in rheumatology: the paradigm of serum autoantibodies.
Sirotti S; Generali E; Ceribelli A; Isailovic N; De Santis M; Selmi C
Auto Immun Highlights; 2017 Dec; 8(1):10. PubMed ID: 28702930
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms of Autoantibody-Induced Pathology.
Ludwig RJ; Vanhoorelbeke K; Leypoldt F; Kaya Z; Bieber K; McLachlan SM; Komorowski L; Luo J; Cabral-Marques O; Hammers CM; Lindstrom JM; Lamprecht P; Fischer A; Riemekasten G; Tersteeg C; Sondermann P; Rapoport B; Wandinger KP; Probst C; El Beidaq A; Schmidt E; Verkman A; Manz RA; Nimmerjahn F
Front Immunol; 2017; 8():603. PubMed ID: 28620373
[TBL] [Abstract][Full Text] [Related]
34. Antinuclear antibody testing - misunderstood or misbegotten?
Pisetsky DS
Nat Rev Rheumatol; 2017 Aug; 13(8):495-502. PubMed ID: 28541299
[TBL] [Abstract][Full Text] [Related]
35. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology.
Halpin P; Williams MV; Klimas NG; Fletcher MA; Barnes Z; Ariza ME
J Med Virol; 2017 Sep; 89(9):1636-1645. PubMed ID: 28303641
[TBL] [Abstract][Full Text] [Related]
36. The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA.
Stearns NA; Zhou S; Petri M; Binder SR; Pisetsky DS
PLoS One; 2016; 11(9):e0161818. PubMed ID: 27611194
[TBL] [Abstract][Full Text] [Related]
37. Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis.
Johnson ME; Grassetti AV; Taroni JN; Lyons SM; Schweppe D; Gordon JK; Spiera RF; Lafyatis R; Anderson PJ; Gerber SA; Whitfield ML
Arthritis Res Ther; 2016 Jan; 18():27. PubMed ID: 26801089
[TBL] [Abstract][Full Text] [Related]
38. The uses and misuses of multiplex autoantibody assays in systemic autoimmune rheumatic diseases.
Satoh M; Tanaka S; Chan EK
Front Immunol; 2015; 6():181. PubMed ID: 25954274
[No Abstract] [Full Text] [Related]
39. Autoantibodies in systemic sclerosis: unanswered questions.
Kayser C; Fritzler MJ
Front Immunol; 2015; 6():167. PubMed ID: 25926833
[TBL] [Abstract][Full Text] [Related]
40. Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies.
Infantino M; Meacci F; Bentow C; Martis P; Benucci M; Afeltra A; Rigon A; Atzeni F; Sarzi-Puttini P; Manfredi M; Mahler M
J Immunol Res; 2015; 2015():902821. PubMed ID: 25759849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
